Drug Profile
Etiprednol
Alternative Names: BNP-166; Cronaze; Ethinase; Etiprednol Dicloacetate; RespicortLatest Information Update: 16 Jan 2008
Price :
$50
*
At a glance
- Originator IVAX Corporation
- Class Anti-inflammatories; Corticosteroids; Small molecules
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Allergic rhinitis; Asthma; Crohn's disease; Ulcerative colitis
Most Recent Events
- 16 Jan 2007 Discontinued - Phase-I for Allergic rhinitis in USA (unspecified route)
- 16 Jan 2007 Discontinued - Phase-II for Asthma in USA (Inhalation)
- 16 Jan 2007 Discontinued - Phase-II for Crohn's disease in USA (PO)